Pages that link to "Q69660017"

The following pages link to Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement (Q69660017):

Displaying 27 items.

• Growth inhibition and apoptosis induction by ( )-Cyanidan-3-ol in hepatocellular carcinoma (Q34873063) (← links)
• Unbiased Selection of Peptide-Peptoid Hybrids Specific for Lung Cancer Compared to Normal Lung Epithelial Cells (Q35824207) (← links)
• Clinical evaluation of total and lipid bound sialic acid levels in oral precancer and oral cancer (Q36064382) (← links)
• Glycoprotein components in the serum of patients with cancer breast (Q36265424) (← links)
• Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1. (Q37327576) (← links)
• Total and lipid bound sialic acid levels in patients with polycystic ovary syndrome (Q37611155) (← links)
• Malignant cell glycoproteins and glycolipids (Q38613949) (← links)
• Salivary lipid peroxidation and total sialic acid levels in smokers and smokeless tobacco users as Maraş powder (Q42026150) (← links)
• Serum total sialic acid in cholangiocarcinoma patients: an ROC curve analysis (Q43818951) (← links)
• Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer (Q44566540) (← links)
• The biochemical and morphological alterations following administration of melatonin, retinoic acid and Nigella sativa in mammary carcinoma: an animal model (Q46339491) (← links)
• Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis (Q46833727) (← links)
• Prevention of rat breast cancer by genistin and selenium (Q51387915) (← links)
• Evaluation of the role of oxidative stress in chemopreventive action of fish oil and celecoxib in the initiation phase of 7,12-dimethyl benz(α)anthracene-induced mammary carcinogenesis (Q51542283) (← links)
• Serum sialylation changes in cancer. (Q55410162) (← links)
• Evaluation of an automated spectrophotometric assay for the determination of total sialic acid in canine serum (Q62989527) (← links)
• Estimation of serum sialic acid in oral submucous fibrosis and oral squamous cell carcinoma (Q64242347) (← links)
• Tumor Markers in Leukemia: Evaluation of Serum Levels of Different Forms of Sialic Acid, Regan Isoenzyme and Lactate Dehydrogenase (Q67859215) (← links)
• Lipid-associated sialic acid levels in human breast cyst fluids (Q70585772) (← links)
• Alterations of glycosidases in human colonic adenocarcinoma (Q73122979) (← links)
• Sialic acid levels in serum and tissue from colorectal cancer patients (Q73147699) (← links)
• Role of Sialic Acid and Alkaline Dnase in Breast Cancer (Q73816617) (← links)
• Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer (Q74201933) (← links)
• Sialic acid concentration in serum and tissue of endometrial cancer patients (Q74240139) (← links)
• Lack of association between serum sialic acid levels and retinopathy in Type 2 diabetic patients (Q77602210) (← links)
• Levels of serum cathepsin L and several glycosidases in patients operated for colorectal cancer (Q78148693) (← links)
• Exploration of the Sialic Acid World (Q90222396) (← links)